Snapshot: November Highlights
A selection of articles you might have missed from November 2022, during which In Vivo shone the spotlight on the Asia Pacific region.
You may also be interested in...
The Belgian start-up is developing a scleral contact lens with an inbuilt LCD screen capable of filtering light – offering a non-surgical solution to a variety of ophthalmic conditions.
The diagnostics company has secured $10m from the foundation to develop a biomarker test for Parkinson’s disease.
Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned.